A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with advanced or recurrent non-squamous non-small cell lung cancer

被引：0
|
作者：
Yabuki, Yohei [1 ]
Otsuka, Kenji [1 ]
Ogino, Hirokazu [1 ]
Takeuchi, Eiji [2 ]
Haku, Takashi [3 ]
Kanematsu, Takanori [4 ]
Nishimura, Naoki [5 ]
Toyoda, Yuko [6 ]
Hanibuchi, Masaki [7 ]
Mitsuhashi, Atsushi [1 ]
Tsukazaki, Yuki [1 ]
Ozaki, Ryohiko [1 ]
Yoneda, Hiroto [1 ]
Nokihara, Hiroshi [1 ]
Nisihioka, Yasuhiko [1 ]
机构：
[1] Tokushima Univ Hosp, Resp Med & Rheumatol, Tokushima, Japan
[2] Natl Hosp Org Kochi Hosp, Dept Clin Invest, Kochi, Japan
[3] Tokushima Prefectural Cent Hosp, Resp Med, Tokushima, Japan
[4] Japanese Red Cross Matsuyama Hosp, Resp Med, Matsuyama, Ehime, Japan
[5] St Lukes Int Hosp, Thorac Ctr, Tokyo, Japan
[6] Japanese Red Cross Kochi Hosp, Internal Med, Kochi, Japan
[7] Shikoku Cent Hosp, Resp Med, Matsuyama, Ehime, Japan
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP08-282
引用
收藏
页码：300 / 300
页数：1
相关论文
共 50 条
  • [41] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Tian, Yaru
    Tian, Hairong
    Zhai, Xiaoyang
    Zhu, Hui
    Yu, Jinming
    FRONTIERS OF MEDICINE, 2022, 16 (04) : 610 - 617
  • [42] Bevacizumab in combination with pemetrexed and platinum for elderly patients with advanced non-squamous non-small-cell lung cancer: a retrospective analysis
    Tian Yaru
    Tian Hairong
    Zhai Xiaoyang
    Zhu Hui
    Yu Jinming
    Frontiers of Medicine, 2022, 16 (04) : 610 - 617
  • [43] Open-label, multicenter, randomized phase III trial of pemetrexed/carboplatin doublet vs pemetrexed singlet in chemotherapy-naive elderly patients aged 70 or more with advanced non-squamous non-small cell lung cancer and good performance status.
    Leek, Dae Ho
    Cho, Eun Kyung
    Ahn, Jin Seok
    Kim, Dong-Wan
    Cho, Byoung Chul
    Lee, Ki Hyeong
    Kim, Sang-We
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Prospective, multicentre, single-arm phase II trial of pembrolizumab combined with carboplatin and pemetrexed in elderly patients with advanced, non-squamous non-small cell lung cancer
    Ozawa, Yuichi
    Sugimoto, Takeya
    Azuma, Yuichiro
    Harutani, Yuhei
    Yoshikawa, Takanori
    Yamamoto, Nobuyuki
    Kanai, Kuninobu
    BMJ OPEN, 2020, 10 (07):
  • [45] Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer
    Lal, R.
    Hillerdal, G. N.
    Shah, R. N. H.
    Crosse, B.
    Thompson, J.
    Nicolson, M.
    Vikstrom, A.
    Potter, V. A.
    Visseren-Grul, C.
    Lorenzo, M.
    D'yachkova, Y.
    Bourayou, N.
    Summers, Y. J.
    LUNG CANCER, 2015, 89 (02) : 154 - 160
  • [46] Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
    Tsutani, Yasuhiro
    Miyata, Yoshihiro
    Masuda, Takeshi
    Fujitaka, Kazunori
    Doi, Mihoko
    Awaya, Yoshikazu
    Kuyama, Shoichi
    Kitaguchi, Soichi
    Ueda, Kazuhiro
    Hattori, Noboru
    Okada, Morihito
    BMC CANCER, 2018, 18
  • [47] Phase II trial of bevacizumab plus pemetrexed and carboplatin in previously untreated advanced nonsquamous non-small cell lung cancer
    Dalsania, C. J.
    Hageboutros, A.
    Harris, E.
    Krieger, K.
    Vora, C.
    Stevenson, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
    Yasuhiro Tsutani
    Yoshihiro Miyata
    Takeshi Masuda
    Kazunori Fujitaka
    Mihoko Doi
    Yoshikazu Awaya
    Shoichi Kuyama
    Soichi Kitaguchi
    Kazuhiro Ueda
    Noboru Hattori
    Morihito Okada
    BMC Cancer, 18
  • [49] PHARMACOGENETIC STUDY OF JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITH PEMETREXED PLUS CISPLATIN
    Imai, Hisao
    Takahashi, Toshiaki
    Serizawa, Masakuni
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Nakamura, Yukiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Koh, Yasuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1077 - S1077
  • [50] Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer
    Nishio, Makoto
    Hida, Toyoaki
    Atagi, Shinji
    Sakai, Hiroshi
    Nakagawa, Kazuhiko
    Takahashi, Toshiaki
    Nogami, Naoyuki
    Saka, Hideo
    Takenoyama, Mitsuhiro
    Maemondo, Makoto
    Ohe, Yuichiro
    Nokihara, Hiroshi
    Hirashima, Tomonori
    Tanaka, Hiroshi
    Fujita, Shiro
    Takeda, Koji
    Goto, Koichi
    Satouchi, Miyako
    Isobe, Hiroshi
    Minato, Koichi
    Sumiyoshi, Naoki
    Tamura, Tomohide
    ESMO OPEN, 2017, 2
12345